Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Galarza

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Acta Neurochirurgica|June 23, 2006
Pure pineal germinomas: analysis of gender incidenceV Cuccia, M Galarza
Journal of Virology|June 8, 2001
Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteinsT Latham, J M Galarza
Clinical Immunology (Orlando, Fla.)|August 7, 2017
Adjuvant formulations for virus-like particle (VLP) based vaccinesVelasco Cimica, Jose M Galarza
Pediatric Neurosurgery|October 12, 2000
Cerebral aspergillosis in children. Report of three casesV Cuccia, M Galarza, J Monges
Viral Immunology|April 2, 2005
Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challengeJose M Galarza, Theresa Latham, Albert Cupo
Translational Andrology and Urology|June 10, 2024
The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in the modern eraGliceida M Galarza Fortuna, Benjamin L Maughan
Viral Immunology|October 13, 2007
A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1)Demetrius Matassov, Albert Cupo, Jose M Galarza
Viral Immunology|July 23, 2005
Virus-like particle vaccine conferred complete protection against a lethal influenza virus challengeJose M Galarza, Theresa Latham, Albert Cupo
Vaccine|November 1, 2018
Dengue-2 virus-like particle (VLP) based vaccine elicits the highest titers of neutralizing antibodies when produced at reduced temperatureHélène Boigard, Velasco Cimica, Jose M Galarza
Pediatric Neurosurgery|October 20, 2001
Acute spinal cord swelling in a child with Chiari II malformationM Galarza, T Gravori, J A Lazareff
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Acta Neurochirurgica|June 23, 2006
Pure pineal germinomas: analysis of gender incidenceV Cuccia, M Galarza
Journal of Virology|June 8, 2001
Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteinsT Latham, J M Galarza
Clinical Immunology (Orlando, Fla.)|August 7, 2017
Adjuvant formulations for virus-like particle (VLP) based vaccinesVelasco Cimica, Jose M Galarza
Pediatric Neurosurgery|October 12, 2000
Cerebral aspergillosis in children. Report of three casesV Cuccia, M Galarza, J Monges
Viral Immunology|April 2, 2005
Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challengeJose M Galarza, Theresa Latham, Albert Cupo
Translational Andrology and Urology|June 10, 2024
The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in the modern eraGliceida M Galarza Fortuna, Benjamin L Maughan
Viral Immunology|October 13, 2007
A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1)Demetrius Matassov, Albert Cupo, Jose M Galarza
Viral Immunology|July 23, 2005
Virus-like particle vaccine conferred complete protection against a lethal influenza virus challengeJose M Galarza, Theresa Latham, Albert Cupo
Vaccine|November 1, 2018
Dengue-2 virus-like particle (VLP) based vaccine elicits the highest titers of neutralizing antibodies when produced at reduced temperatureHélène Boigard, Velasco Cimica, Jose M Galarza
Pediatric Neurosurgery|October 20, 2001
Acute spinal cord swelling in a child with Chiari II malformationM Galarza, T Gravori, J A Lazareff
Pageof 8